â– LECTURE OVERVIEW: Epistaxis (nosebleeds) is a common clinical presentation, most commonly originating from a highly vascularized anatomical zone in the anterior nasal septum.
â– ANASTOMOTIC VASCULAR CHANNELS:
1. Kiesselbach's Plexus: A highly dense, planar arterial network located in the anterior-inferior quadrant of the nasal septum, also termed Little's Area.
2. Five Arterial Inlets:
- Anterior Ethmoidal Artery (from the Ophthalmic/Internal Carotid).
- Posterior Ethmoidal Artery (from the Ophthalmic/Internal Carotid).
- Sphenopalatine Artery (terminal branch of the Maxillary/External Carotid).
- Greater Palatine Artery (from the Maxillary/External Carotid).
- Septal Branch of the Superior Labial Artery (from the Facial/External Carotid).
3. Mucosal Vulnerability: The mucosa overlying Kiesselbach's plexus is exceptionally thin and superficial, leaving the vessels unprotected.
â– THERAPEUTIC TARGETS & MANAGEMENT:
Primary pharmacological intervention aims to restore physiological homeostatic balance. This is achieved by either competitively blocking receptor sites, allosterically inhibiting enzymes, or supplementing missing metabolic products.
â– SUBCLINICAL PHENOTYPE DYNAMICS:
Early physiological shifts typically occur without overt symptom presentation, necessitating highly sensitive laboratory screening to detect disease onset.
[HY-BOARD-1204]
🌟 Dynamic Clinical Key:
Kiesselbach's Plexus is the site of over 90% of all anterior pediatric and adult epistaxis. Bleeding is triggered by local trauma (nose picking), low environmental humidity, or mucosal dry cracks. It is managed with direct compression, anterior nasal packaging, or localization and chemical cautery with silver nitrate. Absolute contraindications include pregnancy, renal insufficiency, or concurrent use of metabolic inhibitors. Monitor high-sensitivity panels regularly in at-risk cohorts to enable timely preventative actions.